BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• News

  Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer

  July 9, 2024

   · 

  2 min read
• News

  Ensysce Biosciences Hosts IASP 2024 Symposium and Presents Clinical Dataset

  July 9, 2024

   · 

  4 min read
• Drug Development

  Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

  July 9, 2024

   · 

  3 min read
• Marvel Highlights New Published Research of Its SAB Member Professor David Blum

  July 9, 2024

   · 

  4 min read
• News

  Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

  July 9, 2024

   · 

  4 min read
• Business

  Global KRAS Inhibitors Drug Sales Is Expected To Surpass USD 600 Million By 2030

  At Present Only 2 Drugs Are Approved In Market With More Than 90 Drugs In Clinical Trials

  July 9, 2024

   · 

  3 min read
• Drug Development

  Bracco Diagnostics Inc. Announces Update on Product Portfolio

  July 9, 2024

   · 

  8 min read
• Business

  SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company

  July 9, 2024

   · 

  3 min read
• News

  Novartis Canada launches $500,000 funding initiative to improve health equity in Canada

  July 9, 2024

   · 

  3 min read
• Business

  Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 08, 2024

  July 9, 2024

   · 

  3 min read